Table 2.
Group | Administration/ Treatment | Body weight (g)/days | ||||
---|---|---|---|---|---|---|
−7 | 1 | 10 | 20 | 30 | ||
I | Normal | 156 ± 8.9a | 163 ± 12.0b | 171 ± 22.7c | 180 ± 17.3d | 191 ± 22.5e |
II | Diabetic | 152 ± 10.2a | 157 ± 6.5b | 153 ± 9.9c | 146 ± 13.6d | 135 ± 11.5e |
III | Xiaoke pill | 151 ± 9.7a | 159 ± 8.6 b | 164 ± 13.7c | 172 ± 15.4d | 181 ± 19.5e |
IV | Crude polysaccharide | 155 ± 7.3a | 161 ± 9.1b | 168 ± 16.3c | 176 ± 14.0d | 184 ± 17.9e |
V | Rhamnose enriched polysaccharide | 158 ± 11.5a | 166 ± 13.3b | 173 ± 17.2c | 180 ± 18.4d | 191 ± 15.9e |
a,b,c,d&eComparisons were made between Groups I, II, III, IV and V.